Zobrazeno 1 - 8
of 8
pro vyhledávání: '"José A Salado-Jimena"'
Publikováno v:
Blood Coagulation & Fibrinolysis. 32:480-490
Inherited thrombocytopenia is a heterogeneous group of hereditary disorders with varying bleeding tendencies, not simply related to platelet count. Platelets transform into different subpopulations upon stimulation, including procoagulant platelets a
Autor:
Johan W.M. Lagerberg, Ido J. Bontekoe, Connie Nielsen, Caroline Verheggen, Folke Knutson, Pieter F. van der Meer, José A Salado-Jimena, Morten Bagge Hansen, Helena Löf, Geert van Waeg, Dirk de Korte
Publikováno v:
Transfusion. 53:1798-1807
Background The Reveos system (Terumo BCT) is a fully automated device able to process four whole blood (WB) units simultaneously into a plasma unit, a red blood cell (RBC) unit, and an interim platelet (PLT) unit (IPU). Multiple IPUs can be pooled to
Autor:
Sisse R Ostrowski, Pär I. Johansson, José A Salado-Jimena, Raymond P. Goodrich, Nis A. Windeløv, Inge Reynaerts, Louise Bochsen
Publikováno v:
Transfusion. 51:344-356
BACKGROUND: Pathogen reduction technologies (PRTs) may influence the hemostatic potential of stored platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) stored in PLT additive solution (SSP+) with or without Mirasol PRT treatment
Autor:
José A Salado-Jimena, Henrik Ullum, Louise Bochsen, Sisse R. Ostrowski, Raymond P. Goodrich, Pär I. Johansson, Inge Reynaerts
Publikováno v:
Transfusion. 50:2210-2219
BACKGROUND: Pathogen reduction technologies (PRTs) may induce storage lesion in platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) in PLT additive solution (AS; SSP+) with or without Mirasol PRT (CaridianBCT Biotechnologies) wer
Autor:
Pär I. Johansson, José A Salado-Jimena, Mette S Svendsen, Rasmus Rojkjaer, Annemarie T. Kristensen, Marianne Kjalke
Publikováno v:
Transfusion. 47:2057-2065
BACKGROUND: The increasing demand for platelet (PLT) transfusions has focused attention on appropriate use. Coated PLTs are a subpopulation of highly procoagulant PLTs formed by simultaneous stimulation by the agonist's collagen and thrombin hypothes
Autor:
Sisse R, Ostrowski, Louise, Bochsen, Nis A, Windeløv, José A, Salado-Jimena, Inge, Reynaerts, Raymond P, Goodrich, Pär I, Johansson
Publikováno v:
Transfusion. 51(2)
Pathogen reduction technologies (PRTs) may influence the hemostatic potential of stored platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) stored in PLT additive solution (SSP+) with or without Mirasol PRT treatment (CaridianBCT
Autor:
Sisse R, Ostrowski, Louise, Bochsen, José A, Salado-Jimena, Henrik, Ullum, Inge, Reynaerts, Raymond P, Goodrich, Pär I, Johansson
Publikováno v:
Transfusion. 50(10)
Pathogen reduction technologies (PRTs) may induce storage lesion in platelet (PLT) concentrates. To investigate this, buffy coat PLTs (BCPs) in PLT additive solution (AS; SSP+) with or without Mirasol PRT (CaridianBCT Biotechnologies) were assessed b
Autor:
Mette S Svendsen, Pär I. Johansson, Louise Bochsen, José A Salado-Jimena, Annemarie T. Kristensen
Publikováno v:
Transfusion. 49(10)
BACKGROUND: Storage can negatively impact the hemostatic potential of platelet concentrates (PCs) used for transfusion. At the site of vascular injury, normal platelets (PLTs) are hypothesized to change into highly procoagulant-coated PLTs upon costi